WuXi XDC Cayman Inc
2268
Rangering i aksjer
#1885
WuXi XDC Cayman Inc. operates as an investment holding company and a global... WuXi XDC Cayman Inc. operates as an investment holding company and a global contract research, development, and manufacturing organization (CRDMO), with operations spanning China, North America, Europe, and other international regions. The company's expertise covers the entire lifecycle, from discovery and research to development and manufacturing, of biopharmaceutical products. Specifically, it focuses on antibody-drug conjugates (ADCs), various bioconjugates, monoclonal antibody intermediates, and the crucial payload-linkers integral to bioconjugate synthesis. Founded in 2013 and headquartered in Wuxi, China, WuXi XDC Cayman Inc. is a subsidiary of WuXi Biologics (Cayman) Inc.
Aksjekurs
$8.78
Markedsverdi
$11.12B
Endring (1 dag)
-9.52%
Endring (1 år)
0.57%
Land
CN
Handel WuXi XDC Cayman Inc (2268)
Kategori
Healthcare
Aksjeprishistorikk for WuXi XDC Cayman Inc (2268)
Høyeste sluttskurs: $10.09 den 2026-10-01
Laveste sluttskurs: $3.64 den 2023-11-01
Laveste sluttskurs: $3.64 den 2023-11-01
Aksjeprishistorikk for WuXi XDC Cayman Inc fra 2023 til 2026
Årlig aksjeprisytelse
| År | Ytelse |
|---|---|
| 2026 (TTM) | -3.96% |
| 2025 | 118.28% |
| 2024 | 0.25% |
| 2023 | 0.00% |
Aksjepris for lignende selskaper eller konkurrenter
| Selskap | Aksjepris | Endring 1år% | Land |
|---|---|---|---|
| $675.61 | 19.11% |
US
|
|
| $229.52 | 5.24% |
US
|
|
| $397.76 | 111.55% |
US
|
|
| $21.16 | 49.45% |
CN
|
|
| $173.53 | 18.96% |
US
|
